Topic

trial results

A collection of 1 issue

Novo Nordisk Shares Fall on CagriSema Trial Setback

Novo Nordisk's stock experienced a decline following underwhelming results from the CagriSema trial, impacting investor sentiment. Stay updated with the latest insights.